-
Tofacitnib Citrate
API Nomen Indicium Specification US DMF EU DMF CEP Tofacitnib Citrate Rheumatoid arthritis In-Domus -
Sugammadex Sodium
API Nomen Indicium Specification US DMF EU DMF CEP Sugammadex Sodium Neuromuscular obsidio In-Domus -
Sacubitril Hemicalcium
API Nomen Indicium Specification US DMF EU DMF CEP Sacubitril Hemicalcium In-Domus -
Sofosbuvir
API Nomen Indicium Specification US DMF EU DMF CEP Sofosbuvir HCV In-Domus 32048 -
Ribociclib 1374639-75-4
API Nomen Indicium Innovator Exitus patentibus Date (US) Ribociclib 1374639-75-4 HR-positivum, HER2-negativum Andvance ormetastaticbreast Cancers Novartis
PharmaceuticalsIun.27, 2028 -
Rivaroxaban
API Nomen Indicium Specification US DMF EU DMF CEP Rivaroxaban Anticoagulant In-Domus TDP -
Rosuvastatin Calcium
API Nomen Indicium Specification US DMF EU DMF CEP Rosuvastatin Calcium Hypercholesterolemia In-Domus/CEP 20705 CEP2015-240 -
Pitavastatin Calcium
API Nomen Indicium Specification US DMF EU DMF CEP Pitavastatin Calcium Hypercholesterolemia In-Domus -
Pregabalin
API Nomen Indicium Specification US DMF EU DMF CEP Pregabalin Comitialis/Neuralgia In-Domus/EP* 22223 CEP2016-141 -
Obeticholic Acidum
API Nomen Indicium Specification US DMF EU DMF CEP Obeticholic Acidum Biliaris cholangitis In-Domus -
Niraparib 1038915-60-4
API Nomen Indicium Innovator Exitus patentibus Date (US) Niraparib 1038915-60-4 Ovarian/Fallopian, fistula/primaria cancer peritonaei Tesaro Jan.8, 2028 -
Ledipasvir Actone / PVP
API Nomen Indicium Specification US DMF EU DMF CEP Ledipasvir Actone / PVP HCV In-Domus
